| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.059 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |